OVERVIEW
In this live symposium, expert faculty will discuss how to approach challenging cases of relapsed/refractory follicular lymphoma (R/R FL) in an increasingly complicated treatment landscape. The discussion will highlight approved, and emerging therapies, and future directions, with the focus on newer therapies such as EZH2 inhibitors, immunomodulators, monoclonal antibodies, chemotherapy, and chimeric antigen receptor (CAR) T cells. The faculty will also explore how these novel and emerging agents fit into a treatment paradigm that has undergone dramatic changes in recent months. A “Case Challenge” breakout session is included that will allow the audience to engage in small-group discussions about a variety of patient management considerations. The program will conclude with a panel discussion and Q&A session with the experts, during which audience members may present challenging cases from their own practices.
GOAL STATEMENT
The goal of this activity is for learners to be better able to integrate the latest data and appropriately sequence therapies to personalize treatment for patients with R/R FL, and to manage therapy-related adverse events to ensure patient treatment adherence and quality of life.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [List][ITEM]Newly approved therapies for treating R/R FL[/list] Have greater competence related to [List][Item]Personalizing treatment for patients with R/R FL [item]Managing treatment-related side effects in patients with R/R FL[/list] Demonstrate greater confidence in their ability to [list][item]Manage patients with R/R FL[/list]
ACCREDITATION STATEMENT
[JALOGO] [MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hyatt Regency New Orleans
Empire A
601 Loyola Ave
New Orleans, Louisiana, 70113
United States
Friday Satellite Symposium on Hematology/Oncology, Preceding the 64th ASH Annual Meeting and Exposition.
Supported by independent educational grants from [bold]Bristol Myers Squibb; and Epizyme, Inc. [/bold]